Synthetic Studies Towards Periglaucines A, B, and Related Bioactive Hasubanans
Periglaucines A、B 和相关生物活性 Hasubanan 的合成研究
基本信息
- 批准号:8516064
- 负责人:
- 金额:$ 1.93万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-08-01 至 2013-12-31
- 项目状态:已结题
- 来源:
- 关键词:AlkaloidsAnalgesicsAntiviral AgentsArchitectureBiologicalBiological FactorsBiologyChemistryComplexDevelopmentDiseaseExhibitsGoalsHepatitis B VirusIminesLeadMethodsMono-SNitrogenPathway interactionsPatientsPharmaceutical PreparationsPharmacologic SubstancePhysical condensationPreparationPropertyQuinonesReactionReagentResearchSourceTherapeutic Agentschemical synthesisketalmembernovelnovel strategies
项目摘要
DESCRIPTION (provided by applicant): Nitrogen-bearing natural products comprise a large number of biologically active molecules, often serving as effective pharmaceuticals in the treatment of disease. Of these, the hasubanan alkaloids possess promising biological activity, exhibiting antihepatotoxic and analgesic properties. In addition, these alkaloids present an intriguing structural architecture characterized by a densely functionalized propellane core. As a result of their biological and structural features, the hasubanans are an attractive target for total synthetic endeavors. The goal of the proposed research is to complete the total synthesis of two members of the hasubanan alkaloids, periglaucines A and B. Key to our synthetic strategy is the development of a diastereoselective 1,2-addition of nucleophiles to quinone imines derived from a chiral auxiliary. The resulting aminodienone products are expected to serve as versatile building blocks in the preparation of more complex propellane alkaloids. By employing a unified synthetic strategy, it is expected that a variety hasubanan alkaloids and derivatives can be readily prepared. With synthetic access to such alkaloids, it will be possible to facilitate studies aimed at elucidating their biological pathways and to potentially develop novel, more potent natural products.
描述(由申请人提供):含氮天然产物包含大量生物活性分子,通常用作治疗疾病的有效药物。其中,hasubanan生物碱具有很好的生物活性,表现出抗肝毒性和镇痛特性。此外,这些生物碱提出了一个有趣的结构架构,其特征在于一个密集的功能化螺桨烷核心。由于它们的生物学和结构特征,hasubanans是全合成努力的有吸引力的目标。 本研究的目标是完成两个hasubanan生物碱成员periglaucines A和B的全合成。我们的合成策略的关键是开发一个非对映选择性的1,2-加成的亲核试剂的醌亚胺衍生的手性助剂。由此产生的氨基二烯酮产物有望在制备更复杂的螺桨烷生物碱中用作多功能的结构单元。通过采用统一的合成策略,有望容易地制备出多种哈苏巴南生物碱及其衍生物。通过合成这些生物碱,将有可能促进旨在阐明其生物学途径的研究,并有可能开发出新的、更有效的天然产物。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Rapid construction of the aza-propellane core of acutumine via a photochemical [2 + 2] cycloaddition reaction.
- DOI:10.1021/ol3017963
- 发表时间:2012-09-07
- 期刊:
- 影响因子:5.2
- 作者:Navarro, Raul;Reisman, Sarah E.
- 通讯作者:Reisman, Sarah E.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Raul Navarro其他文献
Raul Navarro的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Raul Navarro', 18)}}的其他基金
Regiodivergent Palladium-Catalyzed Decarboxylative Coupling of Stabilized Benzylic Nucleophiles
稳定的苄基亲核试剂的区域发散钯催化脱羧偶联
- 批准号:
10731034 - 财政年份:2023
- 资助金额:
$ 1.93万 - 项目类别:
Synthetic Studies Towards Periglaucines A, B, and Related Bioactive Hasubanans
Periglaucines A、B 和相关生物活性 Hasubanan 的合成研究
- 批准号:
8131386 - 财政年份:2011
- 资助金额:
$ 1.93万 - 项目类别:
Synthetic Studies Towards Periglaucines A, B, and Related Bioactive Hasubanans
Periglaucines A、B 和相关生物活性 Hasubanan 的合成研究
- 批准号:
8440392 - 财政年份:2011
- 资助金额:
$ 1.93万 - 项目类别:
相似海外基金
Planning Study for the Development of Sigma 2 ligands as Analgesics
Sigma 2 配体镇痛药开发规划研究
- 批准号:
10641500 - 财政年份:2023
- 资助金额:
$ 1.93万 - 项目类别:
Designing and validating optimal nonaddictive analgesics using the CANDO paradigm
使用 CANDO 范式设计和验证最佳的非成瘾性镇痛药
- 批准号:
10485593 - 财政年份:2023
- 资助金额:
$ 1.93万 - 项目类别:
Identification of botanical hHv1 channel blockers as analgesics for neuropathic pain
植物 hHv1 通道阻滞剂作为神经性疼痛镇痛药的鉴定
- 批准号:
10728526 - 财政年份:2023
- 资助金额:
$ 1.93万 - 项目类别:
Designed Multiple Ligands as Non-opioid Analgesics for Treating Chronic Pain
设计多种配体作为非阿片类镇痛药,用于治疗慢性疼痛
- 批准号:
10621646 - 财政年份:2023
- 资助金额:
$ 1.93万 - 项目类别:
Single-administration microneedles with controlled sustained release of non-opioid analgesics to treat osteoarthritis pain
单次给药微针控制缓释非阿片类镇痛药治疗骨关节炎疼痛
- 批准号:
10425794 - 财政年份:2022
- 资助金额:
$ 1.93万 - 项目类别:
Elucidation of the mechanism of pain suppression by exercise and development of new analgesics
阐明运动镇痛机制及开发新型镇痛药
- 批准号:
22K19602 - 财政年份:2022
- 资助金额:
$ 1.93万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Allosteric Targeting of Cannabinoid CB1 Receptor to Develop Non-Addictive Small Molecule Analgesics
大麻素 CB1 受体变构靶向开发非成瘾性小分子镇痛药
- 批准号:
10512672 - 财政年份:2022
- 资助金额:
$ 1.93万 - 项目类别:
A novel clinically-relevant mouse model of chronic overlapping pain conditions for screening analgesics
用于筛选镇痛药的新型临床相关慢性重叠疼痛小鼠模型
- 批准号:
10821681 - 财政年份:2022
- 资助金额:
$ 1.93万 - 项目类别:
Single-administration microneedles with controlled sustained release of non-opioid analgesics to treat osteoarthritis pain
单次给药微针控制缓释非阿片类镇痛药治疗骨关节炎疼痛
- 批准号:
10721752 - 财政年份:2022
- 资助金额:
$ 1.93万 - 项目类别: